“…Mounjaro, Lilly’s new diabetes drug, brought in $1.41 billion in sales, growing 652% and coming in above estimates for $1.28 billion. Lilly is hoping the Food and Drug Administration will soon approve Mounjaro as a weight-loss drug…” https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q3-2023/?src=A00220